U-Blot® Research Grade UsilnetugCat. No. WA3736Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade UsilnetugCat. No. WA3736
U-Blot® Research Grade UrtoxazumabCat. No. WA3735
U-Blot® Research Grade UrelumabCat. No. WA3734
U-Blot® Research Grade UrabrelimabCat. No. WA3733
U-Blot® Research Grade UprevstobartCat. No. WA3732
U-Blot® Research Grade UpifitamabCat. No. WA3731
U-Blot® Research Grade UpanovimabCat. No. WA3730
U-Blot® Research Grade UmizortamigCat. No. WA3729
U-Blot® Research Grade UmikibartCat. No. WA3728
U-Blot® Research Grade UmesolerbartCat. No. WA3727
U-Blot® Research Grade UlviprubartCat. No. WA3726
U-Blot® Research Grade UlocuplumabCat. No. WA3725